Patient-Reported Outcomes of Brimonidine Tartrate 0.5% Gel for Treatment of Severe Facial Erythema of Rosacea
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Brimonidine (Primary)
- Indications Rosacea
- Focus Registrational; Therapeutic Use
- Acronyms PROOF
- Sponsors Galderma
- 24 Jan 2014 New trial record